There is a newer version of this record available.

Working paper Closed Access

Ivermectin for Covid-19

Sparavigna, Amelia Carolina

Discussion of scholar papers published until June 29, 2020,  on Ivermectin, and of news that we can find about its use for Covid-19.  A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv,  which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19.  From news, we consider in particular the case of Iquitos,  capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably. The formulation of ivermectin used in Peru is also discussed, in particular that of the oral solution disclosed by the Peruvian Government.

Closed Access

Files are not publicly accessible.

All versions This version
Views 2,759294
Downloads 1,044129
Data volume 234.0 MB32.1 MB
Unique views 2,280238
Unique downloads 872114


Cite as